Answers are grounded in this paper and cite their sources.
The manufacturing processes of plasma products include steps that can remove prions. The efficacy of these steps is measured in validation studies using animal brain-derived prion materials called spikes. Because the nature of the prion agent in blood is not known, the relevance of these spikes, particularly with steps that are based on retention mechanisms such as nanofiltration, is important to investigate.
No takes yet. Share an insight, caveat, or question.
Simoneau et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: